Recorded device evidence

FACET SCREW SYSTEM (K101284): indications, design and recorded evidence

The acquired K101284 file contains product-specific indications and users, design and operating principle, recorded comparison and differences, performance evidence actually described sections. Compare these dated manufacturer statements with your own indication and design before commissioning evidence work. They describe this submission; they do not prescribe your testing, validate performance independently or establish a suitable predicate.

Evidence retrieved 2026-10-08. Source versions and topic-specific limits are listed below.

Computed exact-code research

This decision beside its recorded product-code cohort

The 2021–2025 complete-year cohort contains 20 selected decisions under primary code MRW. 20 have valid reported receipt/decision pairs; 0 pairs are missing or invalid.

Calendar elapsed days: lower quartile 49.2, median 93.0, upper quartile 252.5. These are recorded calendar differences, not active FDA review time.

The table shows the named decision and up to four latest exact-code research records through 2026-09-27. It can include partial-year records outside the complete-year cohort. The quartiles above use the full stated cohort, not this displayed selection.

Research recordRecorded deviceReceipt → decisionCalendar elapsed daysRecorded submission type
K101284 ↗ · this pageFACET SCREW SYSTEM2010-05-07 → 2010-07-1569Traditional
K262618 ↗Arthrex Spine Compression FT Screw2026-07-28 → 2026-09-2458Traditional
K261209 ↗Ion-L2026-04-13 → 2026-06-1159Traditional
K253676 ↗CORUS™ Posterior Cervical Stabilization System 3D (CORUS™ PCSS 3D)2025-11-21 → 2026-05-14174Traditional
K253432 ↗DiversiVy™ Facet Screw System2025-10-01 → 2026-03-19169Traditional

Use this comparison: select a record to investigate, read its actual indications and design, and document differences. A shared code or elapsed period cannot establish its relevance to your device.

Calendar elapsed days are not active FDA review time, a promised schedule or a success probability. The selection includes only the stated recorded decisions, not all applications. Latest records can postdate the named historical decision and are contextual research, not its predicates. Shared codes, summaries and observed records do not prove equivalence, current market availability, buyer applicability or predicate suitability.

Calculation, selection and source versions

Reuse the complete-endpoint exact-primary-code, documented SE-decision cohort and its stated cutoff/window. Retain its type-7 quartiles only when at least 20 valid date pairs are present. Independently subtract the named official record’s receipt date from its decision date; missing or negative pairs remain unknown. Show up to four latest exact-code research records, excluding the named ID. Parent analysis hash, source snapshots and calculation versions are retained.

Calculation: fda-named-decision-cohort-context-1; cutoff 2026-09-27; 0 parent records excluded; units record counts; calendar elapsed days.

Source snapshots: 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002.

Read beyond the decision row

Recorded evidence and differences to investigate

The summary is manufacturer-submitted context hosted by FDA. Negative/no-study statements are preserved. Evidence themes are not binding legal requirements.

Short opening excerpts identify the source sections. Read the linked original for the full study context, negative statements, tables and limitations. Public quotations are limited to 120 words per acquired summary; the internal evidence packet retains exact section ranges for review.

Indications and users

K101284 · PDF page 5 ↗ Source 2

The       Nu  Vasive®O          Facet Screw       System             is            intended             to            stabilize           the         spine           as               an            aid           to          ifusion
                                         through                          immobilization                        of              the                         facet                 joints.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

Design and operating principle

K101284 · PDF page 1 ↗ Source 3

The             NuVasive            Facet   Screw            System                 consists                of          fully                  threaded                 and                   partially                threaded
                                             screws                  designed                    to                  compact               juxtaposed                    facet                  articular                   processes                     to                  enhance                      spinal
                                             fusion               and              stability.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

Recorded comparison and differences

K101284 · PDF page 2 ↗ Source 4

As            was            established                 in    this            submission,               the            subject           NuVasive           Facet  Screw       System                  is
             substantially            equivalent       to       other         predicate         devices           cleared         by       the          FDA        for      commercial
             distribution             in              the                United               States.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: The summary’s comparison is a manufacturer statement about that submission. Investigate the actual design differences and cited records before considering any comparator or predicate.

Performance evidence actually described

K101284 · PDF page 2 ↗ Source 4

Nonclinical                 testing                   was              performed                 to             demonstrate                   that            the              subject            NuVasive              Facet
             Screw            System                 is     substantially             equivalent                to                other             predicate             devices.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

Extraction selection and limits

Select observed whole-line section headings or explicit colon-delimited inline labels on readable PDF pages, including the explicitly documented heading-spacing variants in this parser version. Preserve the original heading, character ranges and layout; do not repair excerpt text. Exclude letter boilerplate and uncertain pages. Stop at observed table headings; do not infer table columns or scalar results from layout text. Multi-column or suspicious split-numeric excerpts are excluded until reviewed alternate extraction is available. Original layout records remain retained; any alternate text has its own extractor-version locator and requires original-page review. For each dimension, prefer usable versioned alternate text where available, selecting its longest usable excerpt; otherwise select the longest usable original-layout excerpt. Ties preserve source order. Bounded to 64 PDF pages and 3,500 characters per section. This is a selection, not a complete dossier analysis.

Excluded extraction items: {}.

Known facts and deciding inputs

Known context: US. Confirm the organisation’s role, relevant activities and markets against the cited criteria.

Source factRecorded valueWhat to check
510(k) identifierK101284 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Generic device categoryFACET SCREW SYSTEM [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded applicantNuvasive, Inc. [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
FDA product codeMRW [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Decision date2010-07-15 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded decision codeSESE [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Submission typeTraditional [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Receipt date2010-05-07 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.

Prepare a differences and evidence worksheet

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Indications and users — what differs in our product?

    Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

    Useful evidence: Our proposed indication, user/population and use environment beside this exact recorded indication.

  2. Design and operating principle — what differs in our product?

    Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

    Useful evidence: Design description, materials/components, accessory list and a differences matrix.

  3. Recorded comparison and differences — what differs in our product?

    The summary’s comparison is a manufacturer statement about that submission. Investigate the actual design differences and cited records before considering any comparator or predicate.

    Useful evidence: Feature-by-feature differences and the underlying cited documents; no automated predicate selection.

  4. Performance evidence actually described — what differs in our product?

    The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

    Useful evidence: The cited narrative and full tables, underlying protocols/results and a reviewed comparison with the proposed product.

Work packages and dependencies

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

FDA openFDA — 510(k) decision records ↗

2026-10-05 · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D01 · snapshot 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002

  • [1] device-510k-0001-of-0001.json:results[23231] · record dbef44386472ef023bc23bd686c9316398f5c34e3ef7c7960f75348cb4cb1efc
  • [5] Complete results array / fda-decision-context:K101284 · record whole dataset partition

FDA 510(k) summary — K101284 ↗

Thu, 05 Aug 2010 18:12:16 GMT · retrieved 2026-10-08

Audit details: precise locators and snapshot identifiers

Source key D02 · snapshot 27778236933d90c0861e872c6186f25e3919e3c04cc7071c713b1ee8a30936f8

  • [2] PDF page 5 · record 9b4d35d8676b3a13ef8c59d104b69ebe7dee65d002ad36d45afd7848ebd47425
  • [3] PDF page 1 · record c34c8b562160e87eecef6e2a7aba2f0f1424e569afaefc266c897ca8afe04c03
  • [4] PDF page 2 · record 5f1c8e1956cbab50b1216a2df93e992dcc9e3ed77d69932383a77499eaaf916d

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare FDA 510(k) Submission Services